Work

Individual thrombin generation and spontaneous bleeding rate during personalized prophylaxis with Nuwiq ® (human‐cl rh FVIII ) in previously treated patients with severe haemophilia A

Year: 2018

Type: article

Source: Haemophilia

DOI: 10.1111/hae.13493

Authors: Y. Dargaud, C. Negrier, L. Rusen, J. Windyga, P. Georgiev, J. Bichler, C. Solomon, S. Knaub, T. Lissitchkov, R. Klamroth

Institutions: Hôpital Louis Pradel, Instytut Hematologii i Transfuzjologi, Medical University Plovdiv, University Multipurpose Hospital for Active Treatment "Sveti Georgi", Octapharma (Switzerland), Paracelsus Medical University, National Specialized Hospital for Active Treatment of Hematologic Diseases, Klinikum im Friedrichshain

Language: English

Topic: Hemophilia Treatment and Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Pfizer, Bayer, Baxter International, CSL Behring, Baxalta, Novo Nordisk

OpenAlex ID: W2806756363

FWCI: 1.215

Cites: 35

Cited by: 34

Related to: 10